nonapproval

Nonapproval refers to a decision in which a proposal, application, product, or plan is not approved by an authoritative body. It is the outcome of an evaluation process in which the subject is found not to meet the required criteria, standards, or conditions for authorization. Nonapproval may be final or temporary, depending on the context and the ability to address deficiencies.

Common domains include regulatory and licensing processes (such as medical device or drug approvals), financial lending and funding (where proposals may be declined), contract bidding and procurement, and research or clinical trial applications. In corporate governance, proposals for strategic changes or capital expenditures may be not approved by the board or committees.

Evaluation for nonapproval typically involves risk assessment, compliance checks, safety and efficacy review, and alignment with policy goals. Explanations or written determinations are often provided, listing deficiencies and required corrections if resubmission is permitted.

Outcomes and next steps vary. Applicants may be allowed to modify and resubmit, appeal the decision, or seek alternative channels. In regulatory contexts, nonapproval can trigger additional studies, data submissions, or post-market surveillance requirements before reconsideration.

Related concepts include disapproval, conditional approval, refusal, veto, and rejection. The term is distinct from approval withdrawal, where an existing approval is rescinded.